English: I thank the Member for the series of questions. I think I largely addressed challenges about elective care and waiting lists in response to Andrew R.T. Davies's first set of questions, in acknowledging both that we have a significant challenge to address over a significant period of time, but the fact that the NHS has been progressively opening itself for more work; there is elective care taking place in every single health board. Our challenge is the fact that, in having COVID-secure arrangements for people who come in for elective care, that means we can't do as much activity as we would have done in the past, and, again, the need to prioritise. That goes for a wide range of services, not just cancer, but broader diagnostics. You'll see more detail in our operational framework, but, of course, on cancer, we have already seen the restart of a range of cancer screening programmes, so we are doing that work and we know there is ground to recover. I'm certainly not sanguine or unconcerned about the backlog in not just elective care but in other conditions where significant health harm can be caused, including, of course, some conditions that, left untreated, may prove fatal. When it comes to the challenges about the flu season in particular, I think it's worth reflecting that an average flu season across the UK causes 8,000 to 10,000 deaths, so it's something that we get used to, but, actually, flu does take the lives of lots of people every single year: it reiterates why the flu vaccine programme is so important. In terms of people who may come to harm from flu, of course, they are potentially more vulnerable to COVID as well, so it reinforces the need to get yourself tested and protected against flu, take the jab, but also it's why some of the rapid point-of-care tests are really useful for us, because a range of those will be able to test people for strains of flu as well as COVID. So, there are a range of things in the plan that we've already published today as well as more detail to come in the statements I expect to continue to make to the Senedd through the winter and indeed in the operational framework I've referenced in my opening statement.
Welsh: Diolch i'r Aelod am y gyfres o gwestiynau. Rwy'n credu imi fynd i'r afael i raddau helaeth â heriau ynghylch gofal dewisol a rhestrau aros mewn ymateb i gyfres gyntaf o gwestiynau Andrew R.T. Davies, wrth gydnabod bod gennym ni her sylweddol i ymdrin â hi dros gyfnod sylweddol o amser, a'r ffaith bod y GIG wedi agor yn raddol ar gyfer mwy o waith; mae gofal dewisol yn digwydd ym mhob un bwrdd iechyd. Ein her yw'r ffaith, wrth gael trefniadau diogelu rhag COVID ar gyfer pobl sy'n dod i mewn am ofal dewisol, bod hynny'n golygu na allwn ni wneud cymaint o weithgarwch ag y byddem wedi'i wneud yn y gorffennol, ac, unwaith eto, mae angen blaenoriaethu. Mae hynny'n wir am ystod eang o wasanaethau, nid canser yn unig, ond diagnosteg ehangach. Gallwch weld mwy o fanylion yn ein fframwaith gweithredol, ond, wrth gwrs, o ran canser, rydym eisoes wedi gweld amrywiaeth o raglenni sgrinio canser yn ailgychwyn, felly rydym yn gwneud y gwaith hwnnw a gwyddom fod lle i wella. Yn sicr, nid wyf yn ffyddiog nac yn ddi-bryder ynghylch yr ôl-groniad nid yn unig mewn gofal dewisol ond o ran cyflyrau eraill lle gall achosi niwed sylweddol i iechyd, gan gynnwys, wrth gwrs, rhai cyflyrau a allai, heb eu trin, fod yn angheuol. O ran yr heriau sy'n gysylltiedig â thymor y ffliw yn benodol, rwy'n credu ei bod hi'n werth crybwyll bod tymor ffliw cyfartalog ledled y DU yn achosi 8,000 i 10,000 o farwolaethau, felly mae'n rhywbeth yr ydym yn dod i arfer ag ef, ond, mewn gwirionedd, mae'r ffliw yn cymryd bywydau llawer o bobl bob blwyddyn: mae'n ategu pam y mae'r rhaglen brechu rhag y ffliw mor bwysig. O ran pobl a allai ddioddef o'r ffliw, wrth gwrs, efallai eu bod nhw yn fwy agored i COVID hefyd, felly mae'n atgyfnerthu'r angen i gael eich profi a'ch amddiffyn rhag y ffliw, cael y pigiad, ond hefyd dyna pam y mae rhai o'r profion pwynt gofal cyflym yn ddefnyddiol iawn i ni, oherwydd bydd amrywiaeth o'r rheini'n gallu profi pobl am fathau o ffliw yn ogystal â COVID. Felly, mae amrywiaeth o bethau yn y cynllun yr ydym eisoes wedi'u cyhoeddi heddiw yn ogystal â mwy o fanylion i ddod yn y datganiadau yr wyf yn disgwyl parhau i'w gwneud i'r Senedd drwy'r gaeaf ac yn wir yn y fframwaith gweithredol rwyf wedi cyfeirio ato yn fy natganiad agoriadol.